Josef Niebauer1, Karl Mayr, Hanns Harpf, Peter Hofmann, Edith Müller, Manfred Wonisch, Rochus Pokan, Werner Benzer. 1. University Institute of Sports Medicine, Prevention and Rehabilitation, Institute of Sports Medicine of the State of Salzburg, Sports Medicine of the Olympic Center Salzburg-Rif, Paracelsus Medical University Salzburg, Lindhofstr. 20, 5020, Salzburg, Austria, j.niebauer@salk.at.
Abstract
AIM: Our Working Group on Out-Patient Cardiac Rehabilitation (AGAKAR) has previously published guidelines, which were endorsed by the Austrian Society of Cardiology. It was the aim of this study to assess the short-term (phase II) and long-term (phase III) effects of these guidelines by use of a nationwide registry. METHODS: All Austrian out-patient rehabilitation facilities entered data into a database of all consecutive patients who completed phase II (4-6 weeks) and/or III (6-12 months) rehabilitation between 1.1.2009-30.11.2011. RESULTS: Data of 1432 phase II and 1390 phase III patients were assessed. Despite the wide spectrum of cardiac diseases patients' exercise capacity improved during phase II by 20 (-193 to 240) watts; 91.0% reached a systolic blood pressure <140 mmHg; 68.1% an LDL <100 mg/dl; 69.8% triglycerides <150 mg/dl, and 66.2% of male patients had a waist circumference <102 cm. During phase III improvement in cardiovascular risk factors, quality of life, anxiety, and depression were further improved in an increasing number of patients. CONCLUSIONS: Our data demonstrate beneficial short- and long-term effects of the Austrian model of out-patient cardiac rehabilitation and provide support for comprehensive long-term rehabilitation programs. Furthermore, our model might be helpful for those who are at the verge of initiating or modifying their programs. It is also hoped that these data will motivate colleagues to refer their patients to out-patient cardiac rehabilitation facilities and that our results may stimulate insurance companies to grant further and comprehensive contracts to provide access for all suitable patients.
AIM: Our Working Group on Out-Patient Cardiac Rehabilitation (AGAKAR) has previously published guidelines, which were endorsed by the Austrian Society of Cardiology. It was the aim of this study to assess the short-term (phase II) and long-term (phase III) effects of these guidelines by use of a nationwide registry. METHODS: All Austrian out-patient rehabilitation facilities entered data into a database of all consecutive patients who completed phase II (4-6 weeks) and/or III (6-12 months) rehabilitation between 1.1.2009-30.11.2011. RESULTS: Data of 1432 phase II and 1390 phase III patients were assessed. Despite the wide spectrum of cardiac diseasespatients' exercise capacity improved during phase II by 20 (-193 to 240) watts; 91.0% reached a systolic blood pressure <140 mmHg; 68.1% an LDL <100 mg/dl; 69.8% triglycerides <150 mg/dl, and 66.2% of male patients had a waist circumference <102 cm. During phase III improvement in cardiovascular risk factors, quality of life, anxiety, and depression were further improved in an increasing number of patients. CONCLUSIONS: Our data demonstrate beneficial short- and long-term effects of the Austrian model of out-patient cardiac rehabilitation and provide support for comprehensive long-term rehabilitation programs. Furthermore, our model might be helpful for those who are at the verge of initiating or modifying their programs. It is also hoped that these data will motivate colleagues to refer their patients to out-patient cardiac rehabilitation facilities and that our results may stimulate insurance companies to grant further and comprehensive contracts to provide access for all suitable patients.
Authors: Rod S Taylor; Allan Brown; Shah Ebrahim; Judith Jolliffe; Hussein Noorani; Karen Rees; Becky Skidmore; James A Stone; David R Thompson; Neil Oldridge Journal: Am J Med Date: 2004-05-15 Impact factor: 4.965
Authors: Sidney C Smith; Emelia J Benjamin; Robert O Bonow; Lynne T Braun; Mark A Creager; Barry A Franklin; Raymond J Gibbons; Scott M Grundy; Loren F Hiratzka; Daniel W Jones; Donald M Lloyd-Jones; Margo Minissian; Lori Mosca; Eric D Peterson; Ralph L Sacco; John Spertus; James H Stein; Kathryn A Taubert Journal: Circulation Date: 2011-11-03 Impact factor: 29.690
Authors: Robert Berent; Serge P von Duvillard; Stephen F Crouse; Johann Auer; John S Green; Josef Niebauer; Helmut Sinzinger; Peter Schmid Journal: Int J Cardiol Date: 2012-02-09 Impact factor: 4.164
Authors: G T O'Connor; J E Buring; S Yusuf; S Z Goldhaber; E M Olmstead; R S Paffenbarger; C H Hennekens Journal: Circulation Date: 1989-08 Impact factor: 29.690
Authors: J Niebauer; R Hambrecht; T Velich; K Hauer; C Marburger; B Kälberer; C Weiss; E von Hodenberg; G Schlierf; G Schuler; R Zimmermann; W Kübler Journal: Circulation Date: 1997-10-21 Impact factor: 29.690
Authors: W L Haskell; E L Alderman; J M Fair; D J Maron; S F Mackey; H R Superko; P T Williams; I M Johnstone; M A Champagne; R M Krauss Journal: Circulation Date: 1994-03 Impact factor: 29.690
Authors: D Ornish; S E Brown; L W Scherwitz; J H Billings; W T Armstrong; T A Ports; S M McLanahan; R L Kirkeeide; R J Brand; K L Gould Journal: Lancet Date: 1990-07-21 Impact factor: 79.321
Authors: Dominique Hansen; Josef Niebauer; Veronique Cornelissen; Olga Barna; Daniel Neunhäuserer; Christoph Stettler; Cajsa Tonoli; Eugenio Greco; Robert Fagard; Karin Coninx; Luc Vanhees; Massimo F Piepoli; Roberto Pedretti; Gustavo Rovelo Ruiz; Ugo Corrà; Jean-Paul Schmid; Constantinos H Davos; Frank Edelmann; Ana Abreu; Bernhard Rauch; Marco Ambrosetti; Simona Sarzi Braga; Paul Beckers; Maurizio Bussotti; Pompilio Faggiano; Esteban Garcia-Porrero; Evangelia Kouidi; Michel Lamotte; Rona Reibis; Martijn A Spruit; Tim Takken; Carlo Vigorito; Heinz Völler; Patrick Doherty; Paul Dendale Journal: Sports Med Date: 2018-08 Impact factor: 11.136
Authors: Jürgen Vogel; Andreas Auinger; René Riedl; Harald Kindermann; Markus Helfert; Helmuth Ocenasek Journal: PLoS One Date: 2017-10-11 Impact factor: 3.240